Health
mRNA-based COVID-19 vaccination during pregnancy provides passive SARS-CoV-2 immunity to neonates 16 days after first dose – News-Medical.Net
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger…
Initial clinical trials for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines excluded pregnant women. Thus, pregnant women’s immune response to vaccination and the transplacental transfer of maternal antibodies to the fetus is not yet studied in detail.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part…
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General24 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News14 hours agoTips to improve engagement – Proctor
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland